✦ LIBER ✦

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

✍ Scribed by Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Mineharu Sugimoto

Publisher: Springer
Year: 2006
Tongue: English
Weight: 326 KB
Volume: 16
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-006-0491-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pneumocystis jirovecipneumonia in a pati

Pneumocystis jirovecipneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor α neutralizing antibody

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Kanako Ito; Yukinori Koga; Izum 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 350 KB

Reduction of NOS2 overexpression in rheu

Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor α monoclonal antibody (cA2)

✍ Douglas J. Perkins; E. William St. Clair; Mary A. Misukonis; J. Brice Weinberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

Individualized monitoring of drug bioava

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

✍ Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C. Kapetan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## Objective Infliximab, an anti–tumor necrosis factor α (anti‐TNFα) antibody, is effective in the treatment of several immunoinflammatory diseases. However, many patients experience primary or secondary response failure, suggesting that individualization of treatment regimens may be b

Association between the level of circula

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor

✍ Hubert Marotte; Béatrice Arnaud; Jennifer Diasparra; Saloua Zrioual; Pierre Mios 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Decrease in the levels of anti-cyclic ci

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

✍ Sachiko Onishi; Taku Yoshio; Takao Nagashima; Seiji Minota 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 167 KB

Decrease in cellularity and expression o

Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis

✍ Paul P. Tak; Peter C. Taylor; Ferdinand C. Breedveld; Tom J. M. Smeets; Mohamed 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB